AARD

$5.47+0.20 (+3.80%)

Pre-Market$5.46-0.01 (-0.18%)· Last close May 5

Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases.

Overview Intraday ResearchPRO OptionsPRO BacktestPRO Ask AIPRO TranscriptsPRO StatementsPRO